[Monitoring of cardiac function in anthracycline therapy in childhood].
D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001859:Bone Neoplasms / Q000188:drug therapy; D009202:Cardiomyopathies / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D004317:Doxorubicin / Q000009:adverse effects; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007223:Infant; D009279:Naphthacenes / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D012272:Ribs; D012306:Risk; D012512:Sarcoma, Ewing / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D004317:Doxorubicin
Zur Uberwachung der kardialen Funktion bei Anthrazyklin-Therapie im Kindesalter.